1. Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model
    Damini Chand et al, 2019, Bladder Cancer CrossRef
  2. The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1
    Alexander Sankin et al, 2018, Urologic Oncology: Seminars and Original Investigations CrossRef
  3. B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients
    Yu Yao et al, 2016, Clinical Cancer Research CrossRef
  4. New B7 Family Checkpoints in Human Cancers
    Ling Ni et al, 2017, Molecular Cancer Therapeutics CrossRef
  5. The tissue distribution and significance of B7-H4 in laryngeal carcinoma
    Lili Chen et al, 2017, Oncotarget CrossRef
  6. The third group of the B7‐CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7‐H3
    Murali Janakiram et al, 2017, Immunological Reviews CrossRef
  7. Diagnostic value of soluble B7‐H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion
    Xiaogang Jing et al, 2018, The Clinical Respiratory Journal CrossRef
  8. Identification of metabolism-related key genes as potential biomarkers for pathogenesis of immune thrombocytopenia
    Xiangmei Xu et al, 2024, Scientific Reports CrossRef
  9. Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder
    Tim Mandelkow et al, 2019, Disease Markers CrossRef
  10. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
    Julieta Afonso et al, 2020, Nature Reviews Urology CrossRef
  11. Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A
    Maryam Pourmaleki et al, 2019, Oncotarget CrossRef
  12. Diagnostic value of serum B7-H4 for hepatocellular carcinoma
    Cheng Zhang et al, 2015, Journal of Surgical Research CrossRef
  13. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy
    Muhammad Khan et al, 2021, Frontiers in Immunology CrossRef
  14. Clinical significance of blocking novel immune checkpoint B7-H4 in urothelial carcinoma of bladder as a potential therapeutic target
    David Raja et al, 2024, Medical Oncology CrossRef
  15. B7-H4 facilitates proliferation and metastasis of colorectal carcinoma cell through PI3K/Akt/mTOR signaling pathway
    Chun Li et al, 2020, Clinical and Experimental Medicine CrossRef
  16. B7-H4, a promising target for immunotherapy
    Jia-Yu Wang et al, 2020, Cellular Immunology CrossRef